Patricia Doublet

Prof. Dr. Patricia Doublet

CIRI, Inserm U1111, CNRS UMR5308, Université Lyon 1, ENS Lyon
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2003 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
Ivan MijakovicIvan Mijakovic
Ivan Mijakovic
SPSandrine Poncet
Sandrine Poncet
GBGrégory Boël
Grégory Boël
AMAlain Mazé
Alain Mazé
SGSylvie Gillet
Sylvie Gillet
JDJosef Deutscher
Josef Deutscher
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 May 1993 in Journal of Bacteriology
Verified
Journal Article
Closed access
PDF file
PDPatricia Doublet
Patricia Doublet
JHJ van Heijenoort
J van Heijenoort
JBJ P Bohin
J P Bohin
DMDominique Mengin-Lecreulx
Dominique Mengin-Lecreulx
The murI gene of Escherichia coli was recently identified on the basis of its ability to complement the only mutant requiring D-glutamic acid for growth that had been described to date: strain WM335 of E. coli B/r (P. Doublet, J. van Heijenoort, and D. Mengin-Lecreulx, J. Bacteriol. 174:5772-5779, 1992). We report experiments of insertional mutagenesis of the murI gene which demonstrate that this gene is essential for the biosynthesis of D-glutamic acid, one of the specific components of cell wall peptidoglycan. A special strategy was used for the construction of strains with a disrupted copy of murI, because of a limited capability of E. coli strains grown in rich medium to internalize D-glutamic acid. The murI gene product was overproduced and identified as a glutamate racemase activity. UDP-N-acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala), which is the nucleotide substrate of the D-glutamic-acid-adding enzyme (the murD gene product) catalyzing the subsequent step in the pathway for peptidoglycan synthesis, appears to be an effector of the racemase activity.

1 December 2000 in Journal of Molecular Biology
Verified
Journal Article
Closed access
CVCarole Vincent
Carole Vincent
BDBertrand Duclos
Bertrand Duclos
CGChristophe Grangeasse
Christophe Grangeasse
EVElisabeth Vaganay
Elisabeth Vaganay
MRMylène Riberty
Mylène Riberty
PDPatricia Doublet
Patricia Doublet

1 October 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CGChristophe Grangeasse
Christophe Grangeasse
BOBrice Obadia
Brice Obadia
Ivan MijakovicIvan Mijakovic
Ivan Mijakovic
JDJosef Deutscher
Josef Deutscher
ACAlain J. Cozzone
Alain J. Cozzone
PDPatricia Doublet
Patricia Doublet
Autophosphorylation of protein-tyrosine kinases (PTKs) involved in exopolysaccharide and capsular polysaccharide biosynthesis and transport has been observed in a number of Gram-negative and Gram-positive bacteria. However, besides their own phosphorylation, little is known about other substrates targeted by these protein-modifying enzymes. Here, we present evidence that the protein-tyrosine kinase Wzc of Escherichia coli is able to phosphorylate an endogenous enzyme, UDP-glucose dehydrogenase (Ugd), which participates in the synthesis of the exopolysaccharide colanic acid. The process of phosphorylation of Ugd by Wzc was shown to be stimulated by previous autophosphorylation of Wzc on tyrosine 569. The phosphorylation of Ugd was demonstrated to actually occur on tyrosine and result in a significant increase of its dehydrogenase activity. In addition, the phosphotyrosine-protein phosphatase Wzb, which is known to effectively dephosphorylate Wzc, exhibited only a low effect, if any, on the dephosphorylation of Ugd. These data were related to the recent observation that two other UDP-glucose dehydrogenases have been also shown to be phosphorylated by a PTK in the Gram-positive bacterium Bacillus subtilis. Comparative analysis of the activities of PTKs from Gram-negative and Gram-positive bacteria showed that they are regulated by different mechanisms that involve, respectively, either the autophosphorylation of kinases or their interaction with a membrane protein activator.

1 March 2007 in Journal of Molecular Biology
Verified
Journal Article
Closed access
BOBrice Obadia
Brice Obadia
SLSoline Lacour
Soline Lacour
PDPatricia Doublet
Patricia Doublet
HBHélène Baubichon-Cortay
Hélène Baubichon-Cortay
ACAlain J. Cozzone
Alain J. Cozzone
CGChristophe Grangeasse
Christophe Grangeasse

1 July 2015 in mBio
Verified
Journal Article
Open access
PDF file
CMCéline Michard
Céline Michard
DSDaniel Sperandio
Daniel Sperandio
NBNathalie Baïlo
Nathalie Baïlo
JPJavier Pizarro-Cerdá
Javier Pizarro-Cerdá
LLLawrence LeClaire
Lawrence LeClaire
PDPatricia Doublet
Patricia Doublet
Legionella pneumophila , the etiological agent of legionellosis, replicates within phagocytic cells. Crucial to biogenesis of the replicative vacuole is the Dot/Icm type 4 secretion system, which translocates a large number of effectors into the host cell cytosol. Among them is LegK2, a protein kinase that plays a key role in Legionella infection. Here, we identified the actin nucleator ARP2/3 complex as a target of LegK2. LegK2 phosphorylates the ARPC1B and ARP3 subunits of the ARP2/3 complex. LegK2-dependent ARP2/3 phosphorylation triggers global actin cytoskeleton remodeling in cells, and it impairs actin tail formation by Listeria monocytogenes , a well-known ARP2/3-dependent process. During infection, LegK2 is addressed to the Legionella -containing vacuole surface and inhibits actin polymerization on the phagosome, as revealed by legK2 gene inactivation. Consequently, LegK2 prevents late endosome/lysosome association with the phagosome and finally contributes to remodeling of the bacterium-containing phagosome into a replicative niche. The inhibition of actin polymerization by LegK2 and its effect on endosome trafficking are ARP2/3 dependent since it can be phenocopied by a specific chemical inhibitor of the ARP2/3 complex. Thus, LegK2-ARP2/3 interplay highlights an original mechanism of bacterial virulence with an unexpected role in local actin remodeling that allows bacteria to control vesicle trafficking in order to escape host defenses. IMPORTANCE Deciphering the individual contribution of each Dot/Icm type 4 secretion system substrate to the intracellular life-style of L. pneumophila remains the principal challenge in understanding the molecular basis of Legionella virulence. Our finding that LegK2 is a Dot/Icm effector that inhibits actin polymerization on the Legionella -containing vacuole importantly contributes to the deciphering of the molecular mechanisms evolved by Legionella to counteract the endocytic pathway. Indeed, our results highlight the essential role of LegK2 in preventing late endosomes from fusing with the phagosome. More generally, this work is the first demonstration of local actin remodeling as a mechanism used by bacteria to control organelle trafficking. Further, by characterizing the role of the bacterial protein kinase LegK2, we reinforce the concept that posttranslational modifications are key strategies used by pathogens to evade host cell defenses.